Medical News

---

• Altered cortical responses linked to reduced glutamate levels in ARMS patients
• MDQ may be effective screening tool for postpartum bipolar disorder
• Vegetarian diet reduces metabolic syndrome risk
• Add-on therapy improves endothelial function in hypertriglyceridemic CHD patients
• Symptom perception mechanism differs among EO, NERD patients
• Exenatide more effective in diabetics who also have metabolic syndrome
• Fibroblast growth factor 21 levels predict NAFLD in Type 2 diabetics
• Vegetarian diet reduces metabolic syndrome risk
• Analysis suggests benefit of aspirin in primary prevention
• TAVI associated with myocardial injury

Altered cortical responses linked to reduced glutamate levels in ARMS patients Posted: 18 May 2011 05:00 PM PDT Altered prefrontal, hippocampal, and temporal function is associated with a reduction in thalamic glutamate levels among individuals at high risk for psychosis, research suggests.

MDQ may be effective screening tool for postpartum bipolar disorder Posted: 18 May 2011 05:00 PM PDT The Mood Disorder Questionnaire with alternative scoring criteria may provide an effective screening tool for postpartum bipolar disorder, say Canadian researchers

Vegetarian diet reduces metabolic syndrome risk Posted: 17 May 2011 05:00 PM PDT Individuals who consume a vegetarian diet have a lower risk for developing the metabolic syndrome than those who do not, research suggests.

Add-on therapy improves endothelial function in hypertriglyceridemic CHD patients Posted: 17 May 2011 05:00 PM PDT Ezetimibe add-on therapy can significantly improve lipid profiles and endothelial function in coronary heart disease patients with hypertriglyceridemia, Japanese research suggests.

Symptom perception mechanism differs among EO, NERD patients Posted: 17 May 2011 05:00 PM PDT The mechanisms of symptom generation and perception differ among patients with erosive esophagitis and non-erosive reflux disease, suggest US study findings.

Exenatide more effective in diabetics who also have metabolic syndrome Posted: 17 May 2011 05:00 PM PDT Study results suggest that patients with Type 2 diabetes who have the metabolic syndrome and are treated with the glucagon-like peptide-1 analog exenatide are likely to have a greater reduction in glycated hemoglobin than diabetics without the metabolic syndrome who are treated with the same drug.

Fibroblast growth factor 21 levels predict NAFLD in Type 2 diabetics Posted: 17 May 2011 05:00 PM PDT High levels of fibroblast growth factor 21 are predictive for nonalcoholic fatty liver disease in patients with newly diagnosed Type 2 diabetes, report researchers.

Vegetarian diet reduces metabolic syndrome risk Posted: 17 May 2011 05:00 PM PDT Individuals who consume a vegetarian diet have a lower risk for developing the metabolic syndrome than those who do not, research suggests.

Analysis suggests benefit of aspirin in primary prevention Posted: 17 May 2011 05:00 PM PDT Aspirin may reduce the risk for total cardiovascular events and nonfatal MI when used in primary prevention, a new meta-analysis suggests.

TAVI associated with myocardial injury Posted: 17 May 2011 05:00 PM PDT Canadian researchers report that transcatheter aortic valve implantation may be associated with myocardial injury.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610